{"id":586,"date":"2025-05-13T13:36:07","date_gmt":"2025-05-13T13:36:07","guid":{"rendered":"https:\/\/iefm.health\/public\/?page_id=586"},"modified":"2025-09-24T07:46:09","modified_gmt":"2025-09-24T07:46:09","slug":"webinar-long-covid","status":"publish","type":"page","link":"https:\/\/iefm.health\/public\/webinar\/webinar-long-covid\/","title":{"rendered":"Webinar – Long Covid"},"content":{"rendered":"\n
\n
\n
\n
<\/div>\n\n\n\n

Innovative Therapeutic Approaches for Post-Infectious Diseases<\/h1>\n\n\n\n

<\/h3>\n\n\n\n

Online Webinar – Exclusively for certified Inuspheresis\u00ae practitioners<\/h4>\n\n\n\n

1st July 2025 \u00b7 16.00 – 17.30 \u00b7 Online<\/p>\n<\/div>\n\n\n\n

\n
\"\"<\/figure>\n<\/div>\n<\/div>\n<\/div>\n\n\n\n
\n
<\/div>\n\n\n\n
\n
<\/div>\n<\/div>\n\n\n\n
\n\n\n\n
\n
\n

Webinar Details<\/h2>\n\n\n\n

Click on the individual program items for more information. This webinar was held in English.<\/p>\n<\/div>\n<\/div>\n\n\n\n

\n
\n

16.00 <\/strong> Welcome<\/h4>\n<\/div>\n\n\n\n
\n
\n
Welcome & Introduction<\/summary>\n

Introductory words and organizational information from our host Dr. med. Philip Mavberg (IEFM – Swiss Institute for Environmental and Functional Medicine).<\/p>\n<\/details>\n<\/div>\n<\/div>\n<\/div>\n\n\n\n

\n
\n

16.05<\/strong> Joachim Gerlach
CEO Research & Development, Health Shield<\/h4>\n<\/div>\n\n\n\n
\n
Keynote “Scientific Principles”<\/summary>\n

Joachim Gerlach’s research on Long COVID represents a significant contribution to our understanding of this complex post-viral disease. His account, which links persistent infection, autoimmunity and vascular pathologies, thus provides a comprehensive framework for understanding Long COVID.
The emphasis on the multisystemic nature of Long COVID and the economic and public health implications underscore the importance of continued research in this area. Gerlach’s framework for prioritising treatments thus provides practical guidance for clinicians in a multimodal approach, including in conjunction with Inuspheresis\u00ae, while his ongoing international research projects are helping to further deepen our understanding of this challenging condition.<\/p>\n<\/details>\n<\/div>\n<\/div>\n\n\n\n

\n
\n

16.50<\/strong> Dr. Philip Mavberg
CSO Ayus Medical Group<\/h4>\n<\/div>\n\n\n\n
\n
Keynote “Practical Applications & Therapy Concepts”<\/summary>\n

Learn more about the central mechanisms of Covid\/Long Covid based on current research \u2013 and discover how a multimodal therapeutic approach in combination with Inuspheresis\u00ae treatment can provide targeted support.<\/p>\n<\/details>\n<\/div>\n<\/div>\n\n\n\n

\n
\n

17.05<\/strong> Q&A Session<\/h4>\n<\/div>\n\n\n\n
\n
moderated by Dr. Philip Mavberg<\/summary>\n

You can enter your questions during the keynote presentation via the chat. We will try to answer as many questions as possible during the Q&A session. Alternatively, you can contact us during the Q&A so that we can unlock your microphone and you can ask your question directly.<\/p>\n<\/details>\n<\/div>\n<\/div>\n\n\n\n

<\/div>\n\n\n\n
\n\n\n\n
<\/div>\n\n\n\n

Replay<\/h2>\n\n\n\n

Certified Inuspheresis\u00ae Network Partners can view a recording of this webinar
via our password-protected Brand and Knowledge Hub<\/a>.

If you are interested, please contact us via info@inuspheresis.com<\/a>
and we will create a personal login for you.

<\/h4>\n<\/div>\n\n\n\n
\n
\n\n\n\n
<\/div>\n\n\n\n
<\/div>\n\n\n\n

Speakers<\/h2>\n\n\n\n
\n
<\/div>\n\n\n\n
\n
\"\"
Joachim Gerlach<\/strong> – CEO Research & Development, Health Shield<\/figcaption><\/figure>\n<\/div>\n\n\n\n
\n
\"\"
Dr. Philip Mavberg<\/strong> – CSO Ayus Medical Group<\/figcaption><\/figure>\n<\/div>\n\n\n\n
<\/div>\n<\/div>\n<\/div>\n\n\n\n

<\/p>\n","protected":false},"excerpt":{"rendered":"

Innovative Therapeutic Approaches for Post-Infectious Diseases Online Webinar – Exclusively for certified Inuspheresis\u00ae practitioners 1st July 2025 \u00b7 16.00 – 17.30 \u00b7 Online Webinar Details Click on the individual program items for more information. This webinar was held in English. 16.00 Welcome 16.05 Joachim GerlachCEO Research & Development, Health Shield 16.50 Dr. Philip MavbergCSO Ayus […]<\/p>\n","protected":false},"author":1,"featured_media":0,"parent":433,"menu_order":0,"comment_status":"closed","ping_status":"closed","template":"","meta":{"footnotes":""},"class_list":["post-586","page","type-page","status-publish","hentry"],"_links":{"self":[{"href":"https:\/\/iefm.health\/public\/wp-json\/wp\/v2\/pages\/586","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/iefm.health\/public\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/iefm.health\/public\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/iefm.health\/public\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/iefm.health\/public\/wp-json\/wp\/v2\/comments?post=586"}],"version-history":[{"count":10,"href":"https:\/\/iefm.health\/public\/wp-json\/wp\/v2\/pages\/586\/revisions"}],"predecessor-version":[{"id":678,"href":"https:\/\/iefm.health\/public\/wp-json\/wp\/v2\/pages\/586\/revisions\/678"}],"up":[{"embeddable":true,"href":"https:\/\/iefm.health\/public\/wp-json\/wp\/v2\/pages\/433"}],"wp:attachment":[{"href":"https:\/\/iefm.health\/public\/wp-json\/wp\/v2\/media?parent=586"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}